AlphaYouCR
Insider selling
Christopher R. Cline sold $43K of Travere Therapeutics, Inc. (TVTX) stock
Christopher R. Cline, Chief Financial Officer of Travere Therapeutics, Inc. (TVTX), sold 642 shares of TVTX stock worth $43K, per an SEC Form 4 filed Sep 3, 2026.
It was an open-market sale.
The trade happened on Sep 2, 2026, 1 day before it was made public.
TVTX has moved -10.3% since the trade date, from $67.23 to $60.28 (Sep 22, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 1 day
- Price since
- -10.3%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More TVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.